For research use only. Not for therapeutic Use.
CB1 Agonist 1（Cat No.:I042878）is a selective compound designed to target the CB1 cannabinoid receptor, which is primarily found in the brain and central nervous system. By activating this receptor, CB1 Agonist 1 modulates neurotransmitter release, influencing a variety of physiological processes, including appetite regulation, pain perception, mood, and memory. It is being studied for its potential therapeutic applications in treating conditions like chronic pain, neurodegenerative diseases, and anxiety. Ongoing research focuses on understanding its pharmacological profile, safety, and efficacy in preclinical and clinical settings, particularly in the treatment of neurological disorders.
| CAS Number | 851212-80-1 |
| Synonyms | N-(4-methyl-3-morpholin-4-ylsulfonylphenyl)-2-phenoxybenzamide |
| Molecular Formula | C24H24N2O5S |
| Purity | ≥95% |
| IUPAC Name | N-(4-methyl-3-morpholin-4-ylsulfonylphenyl)-2-phenoxybenzamide |
| InChI | InChI=1S/C24H24N2O5S/c1-18-11-12-19(17-23(18)32(28,29)26-13-15-30-16-14-26)25-24(27)21-9-5-6-10-22(21)31-20-7-3-2-4-8-20/h2-12,17H,13-16H2,1H3,(H,25,27) |
| InChIKey | HASYDUIFQCRDMA-UHFFFAOYSA-N |
| SMILES | CC1=C(C=C(C=C1)NC(=O)C2=CC=CC=C2OC3=CC=CC=C3)S(=O)(=O)N4CCOCC4 |
